Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
146,090,335
-
Share change
-
+146,077,773
-
Total reported value
-
$7,034,389,503
-
Put/Call ratio
-
59%
-
Price per share
-
$48.55
-
Number of holders
-
118
-
Value change
-
+$7,033,778,960
-
Number of buys
-
116
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q2 2020
As of 30 Jun 2020,
Royalty Pharma plc - Common Stock (RPRX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,090,335 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, HARVARD MANAGEMENT CO INC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.